Form 144 Axsome Therapeutics, Filed by: Pizzie Nick
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
- Oil prices settle at pre-Iran war levels as crude output grows
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Broadcom secures role as key Apple supplier with chip deal through 2031
- Dara Khosrowshahi steps down from Grab Holdings board
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
Axsome Therapeutics (AXSM) PT Raised to $200 at Truist Securities
February 18, 2025 1:13 PM ESTTruist Securities analyst Joon Lee raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $200.00 (from $190.00) while maintaining a Buy rating.
The analyst comments "4Q24. No surprises to results preannounced in January. More importantly, Ph3 study of solriamfetol in... More
